Global PCR-based Infectious Diseases Market to 2032
Overview
The Global PCR-based Infectious Diseases Market is expected to reach a 8.28 USD Billion by 2032 and is projected to grow at a CAGR of 7.23% from 2025 to 2032.
Global PCR-based Infectious Diseases Market 2018-2032 USD Billion
Global PCR-based Infectious Diseases Market, Key Findings (2025-2032)
Market Growth and Projections:
- Market Size (2024): 4.95 USD Billion
- Projected Market Size (2032): 8.28 USD Billion
- CAGR (2025-2032): 7.23%
Key Findings of Global PCR-based Infectious Diseases Market
- The Global PCR-based Infectious Diseases Market was valued at 8.28 USD Billion in 2024.
- The Global PCR-based Infectious Diseases Market is likely to grow at a CAGR of 7.23% during the forecast period of 2024 to 2032.
- In 2024, the Largest segment Laboratory Based Testing in Testing Segment accounted for the largest share of the market with a revenue of 3.07 USD Billion
- The fastest growing segment Tuberculosis PCR Test in Test Type Segment grew Fastest with a CAGR of 9.26% during the forecast period from 2024 to 2032.
Global PCR-based Infectious Diseases Market Scope
- Pediatric
- Geriatric
- Adults
- Others
- Multiplex PCR
- RT PCR
- Others
- Protozoa
- Bacterial
- Viral
- Fungal
- Other Infections
- Hospital Acquired Infections
- Sexually Transmitted infection
- Respiratory Tract Infection
- Viral Infection
- Point of Care Testing
- Laboratory Based Testing
- Others
- Home Healthcare
- Academic And Research Institutes
- Community Health Centers
- Clinics
- Hospital
- Diagnostic Centers
- Carbapenem-Resistant Enterobacteriaceae (Cre) PCR Test
- C.Difficile (Clostridium Difficile) PCR Test
- Norovirus PCR Test
- Sars (Covid-19) PCR Test
- H. Pylori PCR Test
- Bordetella PCR Test
- Rotavirus PCR Test
- Salmonellosis PCR Test
- Enterococcus PCR Test
- Gonorrhea PCR Test
- Human Papillomavirus (Hpv) PCR Test
- Influenza PCR Test
- Human Immunodeficiency Virus (Hiv) PCR Test
- Hepatitis PCR Test
- Tuberculosis PCR Test
- Chlamydia Trachomatis Genital PCR Test
- Mycoplasma Genitalium (Mg) PCR Test
- Methicillin-Resistant Staphylococcus Aureus (Mrsa) PCR Test
- Others PCR Test
Global PCR-based Infectious Diseases Market Data Coverage Insights
Study Period | 2024-2032 |
Base Year | 2022 |
Unit | Revenue in USD Billion |
Market Value in 2024 | 4.95 USD Billion |
Market Value in 2032 | 8.28 USD Billion |
CAGR (2025-2032) | 7.23% |
Historic Data | 2016-2023 |
Market Segments Covered | Patient Type,PCR Technology,Pathogen,Infection,Testing,End User,Test Type |
Regional Insights:
-
Leading Market (2024-2032): Global, leading in terms of revenue 4.95 USD Billion in 2024
- Key Country: U.S., leading in terms of revenue with value of 839.97 USD Million in 2024.
Segments and Scope
-
Global PCR-based Infectious Diseases Market to 2032, By Patient Type
- Geriatric is the largest segment in Global PCR-based Infectious Diseases Market to 2032 with a revenue of 2.05 USD Billion in the year 2024.
- Geriatric is the Fastest growing segment in Global PCR-based Infectious Diseases Market to 2032 with a Growth rate of 7.91 % in forecast period 2025-2032.
-
Global PCR-based Infectious Diseases Market to 2032, By PCR Technology
- RT PCR is the largest segment in Global PCR-based Infectious Diseases Market to 2032 with a revenue of 2.09 USD Billion in the year 2024.
- RT PCR is the Fastest growing segment in Global PCR-based Infectious Diseases Market to 2032 with a Growth rate of 7.92 % in forecast period 2025-2032.
-
Global PCR-based Infectious Diseases Market to 2032, By Pathogen
- Viral is the largest segment in Global PCR-based Infectious Diseases Market to 2032 with a revenue of 2.02 USD Billion in the year 2024.
- Viral is the Fastest growing segment in Global PCR-based Infectious Diseases Market to 2032 with a Growth rate of 7.55 % in forecast period 2025-2032.
-
Global PCR-based Infectious Diseases Market to 2032, By Infection
- Viral Infection is the largest segment in Global PCR-based Infectious Diseases Market to 2032 with a revenue of 2.10 USD Billion in the year 2024.
- Viral Infection is the Fastest growing segment in Global PCR-based Infectious Diseases Market to 2032 with a Growth rate of 7.79 % in forecast period 2025-2032.
-
Global PCR-based Infectious Diseases Market to 2032, By Testing
- Laboratory Based Testing is the largest segment in Global PCR-based Infectious Diseases Market to 2032 with a revenue of 3.07 USD Billion in the year 2024.
- Laboratory Based Testing is the Fastest growing segment in Global PCR-based Infectious Diseases Market to 2032 with a Growth rate of 7.47 % in forecast period 2025-2032.
-
Global PCR-based Infectious Diseases Market to 2032, By End User
- Diagnostic Centers is the largest segment in Global PCR-based Infectious Diseases Market to 2032 with a revenue of 1.31 USD Billion in the year 2024.
- Diagnostic Centers is the Fastest growing segment in Global PCR-based Infectious Diseases Market to 2032 with a Growth rate of 8.71 % in forecast period 2025-2032.
-
Global PCR-based Infectious Diseases Market to 2032, By Test Type
- Tuberculosis PCR Test is the largest segment in Global PCR-based Infectious Diseases Market to 2032 with a revenue of 635.20 USD Billion in the year 2024.
- Tuberculosis PCR Test is the Fastest growing segment in Global PCR-based Infectious Diseases Market to 2032 with a Growth rate of 9.26 % in forecast period 2025-2032.
Global PCR-based Infectious Diseases Market Company Share Analysis


Global PCR-based Infectious Diseases Market Geographical Sales Distribution, 2018-2032 USD Billion

Global PCR-based Infectious Diseases Market Company Profiling

Industry Related Reports
Frequently Asked Questions
Global PCR-based Infectious Diseases Market Scope
- Pediatric
- Geriatric
- Adults
- Others
- Multiplex PCR
- RT PCR
- Others
- Protozoa
- Bacterial
- Viral
- Fungal
- Other Infections
- Hospital Acquired Infections
- Sexually Transmitted infection
- Respiratory Tract Infection
- Viral Infection
- Point of Care Testing
- Laboratory Based Testing
- Others
- Home Healthcare
- Academic And Research Institutes
- Community Health Centers
- Clinics
- Hospital
- Diagnostic Centers
- Carbapenem-Resistant Enterobacteriaceae (Cre) PCR Test
- C.Difficile (Clostridium Difficile) PCR Test
- Norovirus PCR Test
- Sars (Covid-19) PCR Test
- H. Pylori PCR Test
- Bordetella PCR Test
- Rotavirus PCR Test
- Salmonellosis PCR Test
- Enterococcus PCR Test
- Gonorrhea PCR Test
- Human Papillomavirus (Hpv) PCR Test
- Influenza PCR Test
- Human Immunodeficiency Virus (Hiv) PCR Test
- Hepatitis PCR Test
- Tuberculosis PCR Test
- Chlamydia Trachomatis Genital PCR Test
- Mycoplasma Genitalium (Mg) PCR Test
- Methicillin-Resistant Staphylococcus Aureus (Mrsa) PCR Test
- Others PCR Test
Frequently Asked Questions
Global PCR-based Infectious Diseases Market Company Profiling

Frequently Asked Questions
HAVE A QUESTION?
Get expert advice on the right strategy for your business at no cost. We also offer customized subscription plans and affordable discounts for startups and universities.